vimarsana.com

Page 30 - தேசிய நோய்த்தடுப்பு ப்ரோக்ர்யாம் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

COVID vaccine education campaigns take targeted approach Here s why

USA TODAY If you ve been waiting for a big national campaign telling you COVID-19 vaccines are safe and everybody should get them, don t hold your breath. Until the supply is plentiful, the federal effort is largely focused on minority communities hesitant about the immunizations. It s a wise approach, experts say.  The kind of one-size-fits-all public service announcements that once blanketed the country won t work for COVID-19 vaccines, they say. Those were for universal messages – only you can prevent forest fires, keep America beautiful, friends don t let friends drive drunk. With COVID-19, different communities need different messages, and mass advertising doesn t necessarily make sense, said Hal Hershfield, a professor of behavioral decision-making at the University of California-Los Angeles Anderson School of Management. 

There s no giant national campaign for COVID-19 vaccine education; experts say there s a better way

GOL announces Monthly Investor Update: Capacity, Cash Consumption and Liquidity

%;  GOL s net cash burn totaled R$1 million a day in January as travel demand cooled and the low season begins. SÃO PAULO, Feb. 11, 2021 /PRNewswire/ GOL Linhas Aéreas Inteligentes S.A. (NYSE: GOL and B3: GOLL4), ( GOL or Company ), Brazil s largest airline, today provides its Investor Update for the month of January of 2021. All information is presented in Brazilian Reais (R$). The information below is preliminary and unaudited. In this period, GOL increased its capacity to an average of 489 flights per day, a 3% increase from an average of 476 flights in December/20. The Company operated approximately 628 daily flights on peak days, serving Customers who flew during the summer vacation. GOL also reached a new record of passengers transported since the beginning of the pandemic with more than 93,000 Customers served in a single day. The Company s consolidated gross revenues for the month were R$810 million and the average load factor was 83.2%, a level consistent

Covid-19: Brazil to have at least 90 million vaccine doses by April

According to the count, 46 million doses of the CoronaVac - developed by Sinovac Life Science in partnership with the Butantan Institute - should be delivered to the Ministry of Health over these first four months of the year. Starting in March, the Oswaldo Cruz Foundation (Fiocruz) will also be actively involved in the National Immunization Program. The first delivery is expected to take place in March, with 15 million doses. Another 27 million should be supplied the following month.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.